Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae.

Frescas, Brian E; McCoy, Christopher M; Kirby, James; Bowden, Robert; Mercuro, Nicholas J

Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae.

Frescas, Brian E; McCoy, Christopher M; Kirby, James; Bowden, Robert; Mercuro, Nicholas J.

Affiliation

Frescas BE; Department of Pharmacy, Christus Spohn Health System, Corpus Christi, TX, USA. Electronic address: brian.frescas@christushealth.org.
McCoy CM; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Kirby J; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Bowden R; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Mercuro NJ; Department of Pharmacy, Maine Medical Center, Portland, ME, USA.

Int J Antimicrob Agents ; 61(5): 106762, 2023 May.

Article de En | MEDLINE | ID: mdl-36804369

Sujet(s)
Mots clés

Bacteremia; Carbapenem; Cefepime; ESBL; Enterobacterales; MIC

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à Klebsiella / Bactériémie / Sepsie / Infections à Escherichia coli Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int J Antimicrob Agents Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google